BioHarvest Sciences Inc. (BHST) Balance Sheet
BHST balance sheet, 2025
December 31, 2025 · U.S. dollars$47.7M assets = $22.2M liabilities + $25.4M equity
Both columns are drawn to the same scale: what BHST owns equals what it owes plus shareholders’ equity. Hover a block for its value.
BHST financial health
Descriptive bands, not a rating. Fiscal 2025.
BHST balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $61,6062016 | $47.7M2025 | +109.4%/yr | |
| Total liabilities | $121,1752016 | $22.2M2025 | +78.4%/yr | |
| Shareholders’ equity | −$59,5692016 | $25.4M2025 | — | |
| Cash & short-term investments | $1,3572016 | $23.0M2025 | +195.1%/yr | |
| Total debt | $80,9402016 | $14.1M2025 | +77.4%/yr | |
| Net cash (debt) | −$79,5832016 | $8.9M2025 | +$9.0M | |
| Working capital | −$118,8032016 | $22.8M2025 | +$22.9M | |
| Book value per share | −$0.242020 | $1.382025 | — | |
| Current ratio | 0.022016 | 3.972025 | +3.95 | |
| Debt / equity | 0.032017 | 0.552025 | +0.52 | |
| Shares outstanding | 9.7M2020 | 18.4M2025 | +13.6%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BHST assets
BHST liabilities and equity
BHST debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
BHST balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $23.0M | $2.4M | $5.4M | $1.7M | $4.1M | $1.8M | $911,000 | $395,607 | $216,289 | $1,357 |
| Cash & equivalents | $23.0M | $2.4M | $5.4M | $1.7M | $4.1M | $1.8M | $911,000 | $395,607 | $216,289 | $1,357 |
| Receivables | $2.2M | $1.3M | $968,000 | $722,000 | $620,000 | $354,000 | $281,000 | $10,209 | $2,239 | $1,014 |
| Inventory | $4.6M | $3.7M | $2.5M | $1.4M | $928,000 | $100,000 | $51,000 | $0 | $0 | $0 |
| Other current assets | $673,000 | $469,000 | $263,000 | $486,000 | $0 | $0 | $0 | $239,649 | $0 | $1 |
| Total current assets | $30.5M | $7.9M | $9.1M | $4.3M | $5.7M | $2.2M | $1.2M | $645,465 | $218,528 | $2,372 |
| Property, plant & equipment (net) | $16.7M | $16.8M | $5.8M | $4.9M | $4.4M | $2.9M | $651,000 | $0 | $83,218 | $59,234 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.5M | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $433,000 | $371,000 | $179,000 | $163,000 | $179,000 | $144,000 | $127,999 | $0 | $1 | $0 |
| Total assets | $47.7M | $25.0M | $15.0M | $9.4M | $10.2M | $5.3M | $2.0M | $4.2M | $301,747 | $61,606 |
| Liabilities | ||||||||||
| Accounts payable | $2.6M | $3.5M | $1.8M | $1.1M | $875,000 | $435,000 | $403,000 | $20,077 | $27,699 | $40,235 |
| Short-term debt | $1.6M | $4.7M | $20.9M | $8.9M | $386,000 | $319,000 | $23.7M | — | $8,105 | $80,940 |
| Deferred revenue | $492,000 | $1.3M | $836,000 | $394,000 | — | — | — | — | — | — |
| Total current liabilities | $7.7M | $14.3M | $26.5M | $11.5M | $2.9M | $1.9M | $26.5M | $20,077 | $27,699 | $121,175 |
| Long-term debt | $2.4M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $11.5M | $9.9M | $1.8M | $2.0M | $2.7M | $2.4M | — | — | — | — |
| Other long-term liabilities | $12.1M | $9.4M | $3.4M | $3.8M | $4.4M | $5.7M | $2.5M | $1.4M | $0 | $0 |
| Total liabilities | $22.2M | $23.7M | $29.9M | $15.3M | $7.4M | $7.6M | $29.0M | $1.4M | $27,699 | $121,175 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $133.0M | $97.7M | $68.7M | $65.0M | $62.6M | $47.6M | $25,000 | — | — | — |
| Retained earnings (deficit) | −$107.6M | −$96.4M | −$83.5M | −$70.9M | −$59.7M | −$49.9M | −$41.5M | −$3.8M | −$465,614 | −$300,385 |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | $6,525 | $9,602 |
| Total shareholders' equity | $25.4M | $1.3M | −$14.9M | −$5.9M | $2.9M | −$2.3M | −$30.5M | $2.8M | $274,048 | −$59,569 |
| Key figures | ||||||||||
| Total debt | $14.1M | $13.8M | $22.3M | $10.6M | $2.7M | $2.7M | $26.2M | — | $8,105 | $80,940 |
| Net cash (debt) | $8.9M | −$11.4M | −$17.0M | −$8.8M | $1.5M | −$932,000 | −$25.3M | — | $208,184 | −$79,583 |
| Working capital | $22.8M | −$6.4M | −$17.4M | −$7.2M | $2.7M | $343,000 | −$25.2M | $625,388 | $190,829 | −$118,803 |
| Tangible book value | $25.4M | $1.3M | −$14.9M | −$5.9M | $2.9M | −$2.3M | −$30.5M | −$773,369 | $274,048 | −$59,569 |
| Book value per share | $1.38 | $0.08 | −$1.10 | −$0.45 | $0.23 | −$0.24 | — | — | — | — |
| Shares outstanding | 18.4M | 16.2M | 13.5M | 13.1M | 12.4M | 9.7M | — | — | — | — |
| Current ratio | 3.97 | 0.55 | 0.34 | 0.38 | 1.94 | 1.18 | 0.05 | 32.15 | 7.89 | 0.02 |
| Quick ratio | 3.29 | 0.26 | 0.24 | 0.21 | 1.62 | 1.13 | 0.05 | 20.21 | 7.89 | 0.02 |
| Debt / equity | 0.55 | 10.39 | — | — | 0.93 | — | — | — | 0.03 | — |
| Equity / assets | 53.4% | 5.3% | −99.0% | −63.1% | 28.0% | −43.3% | −1,510.1% | 66.1% | 90.8% | −96.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $16.2M | $19.2M | $23.0M | $11.0M | $3.7M | $3.4M | $2.4M | $2.8M | $5.2M | $3.4M | $5.4M | $1.6M |
| Cash & equivalents | $16.2M | $19.2M | $23.0M | $11.0M | $3.7M | $3.4M | $2.4M | $2.8M | $5.2M | $3.4M | $5.4M | $1.6M |
| Short-term investments | $1.0M | $1.0M | — | — | — | — | — | — | — | — | — | — |
| Receivables | $4.2M | $3.2M | $2.2M | $2.4M | $2.5M | $2.2M | $1.3M | $2.0M | $1.5M | $1.4M | $968,000 | $1.1M |
| Inventory | $5.8M | $5.0M | $4.6M | $4.4M | $4.1M | $4.0M | $3.7M | $3.2M | $2.6M | $2.7M | $2.5M | $2.1M |
| Other current assets | $1 | $1.0M | $673,000 | $0 | $0 | $0 | $469,000 | $0 | $0 | $0 | $263,000 | $0 |
| Total current assets | $26.2M | $28.3M | $30.5M | $17.8M | $10.3M | $9.6M | $7.9M | $8.0M | $9.3M | $7.6M | $9.1M | $4.7M |
| Property, plant & equipment (net) | $17.9M | $16.8M | $16.7M | $16.9M | $17.1M | $16.6M | $16.8M | $17.5M | $17.4M | $5.2M | $5.8M | $5.7M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $463,000 | $436,000 | $433,000 | $405,000 | $397,000 | $361,000 | $371,000 | $364,000 | $401,000 | $163,000 | $179,000 | $173,000 |
| Total assets | $44.6M | $45.6M | $47.7M | $35.2M | $27.8M | $26.6M | $25.0M | $25.8M | $27.0M | $12.9M | $15.0M | $10.6M |
| Liabilities | ||||||||||||
| Accounts payable | $2.7M | $2.7M | $2.6M | $3.5M | $3.4M | $3.7M | $3.5M | $4.4M | $4.0M | $2.1M | $1.8M | $1.8M |
| Short-term debt | $4.4M | $3.5M | $1.6M | $5.6M | $6.2M | $8.6M | $4.7M | $1.2M | $1.2M | $8.0M | $20.9M | $10.0M |
| Deferred revenue | $415,000 | $474,000 | $492,000 | $438,000 | $990,000 | $1.1M | $1.3M | — | — | — | $836,000 | — |
| Total current liabilities | $11.7M | $9.6M | $7.7M | $13.2M | $17.1M | $18.9M | $14.3M | $9.9M | $8.9M | $13.3M | $26.5M | $14.6M |
| Long-term debt | $0 | $786,000 | $2.4M | $2.3M | $5.3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $13.0M | $11.5M | $11.5M | $11.3M | $11.1M | $9.6M | $9.9M | $9.5M | $9.2M | $726,000 | $1.8M | $1.4M |
| Other long-term liabilities | $13.1M | $12.2M | $12.1M | $11.9M | $9.7M | $8.5M | $9.4M | $11.8M | $11.4M | $2.8M | $3.4M | $3.7M |
| Total liabilities | $24.8M | $22.5M | $22.2M | $27.5M | $32.0M | $27.5M | $23.7M | $21.7M | $20.3M | $16.1M | $29.9M | $18.3M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $133.7M | $133.2M | $133.0M | $113.1M | $98.6M | $97.9M | $97.7M | $97.6M | $97.5M | $86.9M | $68.7M | $68.5M |
| Retained earnings (deficit) | −$113.9M | −$110.2M | −$107.6M | −$105.3M | −$102.8M | −$98.8M | −$96.4M | −$93.5M | −$90.8M | −$90.1M | −$83.5M | −$76.3M |
| Total shareholders' equity | $19.8M | $23.0M | $25.4M | $7.7M | −$4.2M | −$876,000 | $1.3M | $4.1M | $6.7M | −$3.2M | −$14.9M | −$7.8M |
| Key figures | ||||||||||||
| Total debt | $17.5M | $16.4M | $14.1M | $19.8M | $21.1M | $17.1M | $13.8M | $10.7M | $10.4M | $8.7M | $22.3M | $11.4M |
| Net cash (debt) | −$1.3M | $2.8M | $8.9M | −$8.9M | −$17.4M | −$13.7M | −$11.4M | −$7.9M | −$5.2M | −$5.3M | −$17.0M | −$9.9M |
| Working capital | $14.5M | $18.7M | $22.8M | $4.6M | −$6.8M | −$9.3M | −$6.4M | −$1.9M | $317,000 | −$5.8M | −$17.4M | −$9.9M |
| Tangible book value | $19.8M | $23.0M | $25.4M | $7.7M | −$4.2M | −$876,000 | $1.3M | $4.1M | $6.7M | −$3.2M | −$14.9M | −$7.8M |
| Book value per share | $0.87 | $1.02 | $1.38 | $0.44 | −$0.24 | −$0.05 | $0.08 | $0.24 | $0.41 | −$0.23 | −$1.11 | −$0.58 |
| Shares outstanding | 22.7M | 22.7M | 18.4M | 17.4M | 17.3M | 17.3M | 17.3M | 17.3M | 16.3M | 13.7M | 13.4M | 13.4M |
| Current ratio | 2.24 | 2.96 | 3.97 | 1.35 | 0.60 | 0.51 | 0.55 | 0.80 | 1.04 | 0.57 | 0.34 | 0.32 |
| Quick ratio | 1.75 | 2.33 | 3.29 | 1.02 | 0.36 | 0.30 | 0.26 | 0.48 | 0.75 | 0.37 | 0.24 | 0.18 |
| Debt / equity | 0.89 | 0.71 | 0.55 | 2.57 | — | — | 10.39 | 2.58 | 1.55 | — | — | — |
| Equity / assets | 44.3% | 50.5% | 53.4% | 22.0% | −15.2% | −3.3% | 5.3% | 16.0% | 24.8% | −24.7% | −99.0% | −73.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 31, 2026); data from EODHD.
BHST financial position
At the end of fiscal 2025 (December 31, 2025), BioHarvest Sciences had total assets of $47.7 million (up 90.7% from a year earlier), total liabilities of $22.2 million and shareholders' equity of $25.4 million. It held $23.0 million in cash and short-term investments against $14.1 million of debt, a net cash position of $8.9 million. Its current ratio was 3.97. In the latest quarter (ended June 30, 2026) total assets were $44.6 million and equity $19.8 million.
Related: BHST income statement, BHST cash flow statement, BHST key metrics. See the BHST stock overview for the latest quote and news.
BHST balance sheet FAQ
What are BioHarvest Sciences's total assets?
BioHarvest Sciences reported total assets of $47.7 million at the end of fiscal 2025 (December 31, 2025), compared with $25.0 million a year earlier.
How much debt does BioHarvest Sciences have?
BioHarvest Sciences had $14.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.55.
How much cash does BioHarvest Sciences have?
BioHarvest Sciences held $23.0 million in cash and short-term investments at the end of fiscal 2025; with $14.1 million of debt that is net cash of $8.9 million.
What is BioHarvest Sciences's book value?
BioHarvest Sciences's shareholders' equity (book value) was $25.4 million at the end of fiscal 2025, or $1.38 per share.
What is BioHarvest Sciences's current ratio?
BioHarvest Sciences had current assets of $30.5 million and current liabilities of $7.7 million, a current ratio of 3.97 (it can cover its short-term obligations).